Disease gene interaction pathways: A potential framework for how disease genes associate by disease-risk modules

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Chen, Lina ^a   Li, Wan ^a   Zhang, Liangcai ^a   Wang, Hong ^a   He, Weiming ^b   Tai, Jingxie ^a   Li, Xu ^a   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; MOLECULAR BIOLOGY; MOLECULAR GENETICS; RISK ASSESSMENT; ALGORITHM; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; HUMAN; PHYSIOLOGY;

ALGORITHMS; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS;

EID: 80052450814     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024495     Document Type: Article

References (66)

1. Qiu YQ, Zhang S, Zhang XS, Chen L, (2010) Detecting disease associated modules and prioritizing active genes based on high throughput data. BMC Bioinformatics 11: 26.
2. Ostlund G, Lindskog M, Sonnhammer EL, (2010) Network-based Identification of novel cancer genes. Mol Cell Proteomics 9: 648-655.
3. Gu J, Chen Y, Li S, Li Y, (2010) Identification of responsive gene modules by network-based gene clustering and extending: application to inflammation and angiogenesis. BMC Syst Biol 4: 47.
4. Mocellin S, Rossi CR, Traldi P, Nitti D, Lise M, (2004) Molecular oncology in the post-genomic era: the challenge of proteomics. Trends Mol Med 10: 24-32.
5. Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, et al. (2004) Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res 64: 7678-7681.
6. Khalil AS, Collins JJ, (2010) Synthetic biology: applications come of age. Nat Rev Genet 11: 367-379.
7. Kind T, Scholz M, Fiehn O, (2009) How large is the metabolome? A critical analysis of data exchange practices in chemistry. PLoS One 4: e5440.
8. Chang L, Karin M, (2001) Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
9. Bertram L, Tanzi RE, (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9: 768-778.
10. Thomas P, Fenech M, (2007) A review of genome mutation and Alzheimer's disease. Mutagenesis 22: 15-33.
11. Frisch M, Klocke B, Haltmeier M, Frech K, (2009) LitInspector: literature and signal transduction pathway mining in PubMed abstracts. Nucleic Acids Res 37: W135-140.
12. Faust K, Dupont P, Callut J, van Helden J, (2010) Pathway discovery in metabolic networks by subgraph extraction. Bioinformatics 26: 1211-1218.
13. Dale JM, Popescu L, Karp PD, (2010) Machine learning methods for metabolic pathway prediction. BMC Bioinformatics 11: 15.
14. Gerlee P, Lizana L, Sneppen K, (2009) Pathway identification by network pruning in the metabolic network of Escherichia coli. Bioinformatics 25: 3282-3288.
15. Mithani A, Preston GM, Hein J, (2009) Rahnuma: hypergraph-based tool for metabolic pathway prediction and network comparison. Bioinformatics 25: 1831-1832.
16. Clement K, Gustafson N, Berbert A, Carroll H, Merris C, et al. (2010) PathGen: a transitive gene pathway generator. Bioinformatics 26: 423-425.
17. Qian X, Yoon BJ, (2009) Effective identification of conserved pathways in biological networks using hidden Markov models. PLoS One 4: e8070.
18. Qian X, Sze SH, Yoon BJ, (2009) Querying pathways in protein interaction networks based on hidden Markov models. J Comput Biol 16: 145-157.
19. Shlomi T, Segal D, Ruppin E, Sharan R, (2006) QPath: a method for querying pathways in a protein-protein interaction network. BMC Bioinformatics 7: 199.
20. Segal E, Wang H, Koller D, (2003) Discovering molecular pathways from protein interaction and gene expression data. Bioinformatics 19 (Suppl 1): i264-271.
21. Steffen M, Petti A, Aach J, D'Haeseleer P, Church G, (2002) Automated modelling of signal transduction networks. BMC Bioinformatics 3: 34.
22. Bebek G, Yang J, (2007) PathFinder: mining signal transduction pathway segments from protein-protein interaction networks. BMC Bioinformatics 8: 335.
23. Supper J, Spangenberg L, Planatscher H, Drager A, Schroder A, et al. (2009) BowTieBuilder: modeling signal transduction pathways. BMC Syst Biol 3: 67.
24. Huffner F, Wernicke S, Zichner T, (2007) Faspad: fast signaling pathway detection. Bioinformatics 23: 1708-1709.
25. Scott J, Ideker T, Karp RM, Sharan R, (2006) Efficient algorithms for detecting signaling pathways in protein interaction networks. J Comput Biol 13: 133-144.
26. Zhang KX, Ouellette BF, (2010) Pandora, a pathway and network discovery approach based on common biological evidence. Bioinformatics 26: 529-535.
27. Dezso Z, Nikolsky Y, Nikolskaya T, Miller J, Cherba D, et al. (2009) Identifying disease-specific genes based on their topological significance in protein networks. BMC Syst Biol 3: 36.
28. Berger SI, Posner JM, Ma'ayan A, (2007) Genes2Networks: connecting lists of gene symbols using mammalian protein interactions databases. BMC Bioinformatics 8: 372.
29. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL, (2002) Hierarchical organization of modularity in metabolic networks. Science 297: 1551-1555.
30. Kelley R, Ideker T, (2005) Systematic interpretation of genetic interactions using protein networks. Nat Biotechnol 23: 561-566.
31. Li H, Liang S, (2009) Local network topology in human protein interaction data predicts functional association. PLoS One 4: e6410.
32. Li A, Horvath S, (2007) Network neighborhood analysis with the multi-node topological overlap measure. Bioinformatics 23: 222-231.
33. Rives AW, Galitski T, (2003) Modular organization of cellular networks. Proc Natl Acad Sci U S A 100: 1128-1133.
34. Sales-Pardo M, Guimera R, Moreira AA, Amaral LA, (2007) Extracting the hierarchical organization of complex systems. Proc Natl Acad Sci U S A 104: 15224-15229.
35. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res 37: D767-772.
36. Du P, Feng G, Flatow J, Song J, Holko M, et al. (2009) From disease ontology to disease-ontology lite: statistical methods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics 25: i63-68.
37. McKusick VA, (2007) Mendelian Inheritance in Man and its online version, OMIM. Am J Hum Genet 80: 588-604.
38. Becker KG, Barnes KC, Bright TJ, Wang SA, (2004) The genetic association database. Nat Genet 36: 431-432.
39. Shimizu A, Kimoto T, Kobatake H, Nawano S, Shinozaki K, (2010) Automated pancreas segmentation from three-dimensional contrast-enhanced computed tomography. Int J Comput Assist Radiol Surg 5: 85-98.
40. Lu L, Jin CH, Zhou T, (2009) Similarity index based on local paths for link prediction of complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 80: 046122.
41. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
42. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
43. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
44. Merskey C, Gordon H, Lackner H, Schrire V, Kaplan BJ, et al. (1960) Blood Coagulation and Fibrinolysis in Relation to Coronary Heart Disease. Br Med J 1: 219-227.
45. Davies JA, (1980) Blood coagulation in relation to coronary heart disease. Acta Med Scand Suppl 642 pp. 141-145.
46. Yamagishi K, Aleksic N, Hannan PJ, Folsom AR, (2010) Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease. J Atheroscler Thromb 17: 402-409.
47. Brazionis L, Rowley K, Jenkins A, Itsiopoulos C, O'Dea K, (2008) Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy. Arterioscler Thromb Vasc Biol 28: 786-791.
48. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M, (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38: D355-360.
49. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, et al. (2006) From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 34: D354-357.
50. Kanehisa M, Goto S, (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30.
51. Huang X, Zhang XY, Qin F, Wang XY, Ren P, et al. (2010) Pretreatment with a traditional Chinese formula, guanxin II, reduces cardiac apoptosis via the Akt survival pathway in rats with myocardial ischemia. Tohoku J Exp Med 220: 157-163.
52. Deftereos S, Giannopoulos G, Kossyvakis C, Kaoukis A, Raisakis K, et al. (2010) Effect of quinapril on in-stent restenosis and relation to plasma apoptosis signaling molecules. Am J Cardiol 105: 54-58.
53. Yu X, Song M, Chen J, Zhu G, Zhao G, et al. (2009) Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway. Mol Biol Rep.
54. Wilensky RL, Macphee CH, (2009) Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr Opin Lipidol 20: 415-420.
55. Borinskaia SA, Kal'ina NR, Sanina ED, Kozhekbaeva Zh M, Gupalo E, et al. (2007) [Polymorphism of the apolipoprotein E gene (APOE) in the populations of Russia and neighboring countries]. Genetika 43: 1434-1440.
56. Zeng Y, Miao F, Li L, Sun DH, Xu XM, (2007) A rapid and accurate DHPLC assay for determination of apolipoprotein E genotypes. J Alzheimers Dis 12: 357-363.
57. Bazrgar M, Karimi M, Fathzadeh M, Senemar S, Peiravian F, et al. (2008) Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts. Mol Biol Rep 35: 495-499.
58. Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, et al. (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem 111: 1275-1308.
59. Segev A, Nili N, Strauss BH, (2004) The role of perlecan in arterial injury and angiogenesis. Cardiovasc Res 63: 603-610.
60. Frost G, Brynes A, Leeds A, (1999) Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease. Nutrition 15: 183-188.
61. McGeachie M, Ramoni RL, Mychaleckyj JC, Furie KL, Dreyfuss JM, et al. (2009) Integrative predictive model of coronary artery calcification in atherosclerosis. Circulation 120: 2448-2454.
62. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169.
63. McCarthy JJ, Parker A, Salem R, Moliterno DJ, Wang Q, et al. (2004) Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 41: 334-341.
64. McCarthy JJ, Meyer J, Moliterno DJ, Newby LK, Rogers WJ, et al. (2003) Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet 114: 87-98.
65. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55.
66. Nelson MR, Kardia SL, Ferrell RE, Sing CF, (2001) A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res 11: 458-470.